Management of patent ductus arteriosus – Evidence to practice
<p dir="ltr">Over the past last 50 years, <u>patent ductus arteriosus</u> (PDA) continues to be the leading hot topic debated worldwide in search of best treatment approach and the uncertainty around whether to treat or not treat a PDA. With the availability of bedside &l...
Saved in:
| Main Author: | Samir Gupta (584529) (author) |
|---|---|
| Other Authors: | Steven M. Donn (17052417) (author) |
| Published: |
2024
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Indomethacin as a Rescue Therapy for Patent Ductus Arteriosus in Extremely Premature Infants after Failed Ibuprofen Treatment
by: Amal Sabouni (17046236)
Published: (2023) -
Cost-Effectiveness Analysis of Ibuprofen Versus Indomethacin or Paracetamol for the Treatment of Patent Ductus Arteriosus in Preterm Neonates
by: Samaher Al-Shaibi (14152206)
Published: (2023) -
Oxygen therapy in preterm infants: recommendations for practice
by: Sanoj. K.M. Ali (17058036)
Published: (2020) -
Post-discharge outcomes associated with bronchopulmonary dysplasia in extremely low birth weight infants: A retrospective chart review study.
by: Thomas Mathen Maveli (17046295)
Published: (2023) -
Revisting definition of bronchopulmonwry dysplaisa
by: Manar Saleh (17046232)
Published: (2023)